Computational Pathology Market Size, Share & Trends Report

Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software, Services) By Application, By Technology (Natural Language Processing Models), By End-use (Hospitals & Diagnostic Labs), By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68040-548-5
Number of Report Pages: 100
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Computational Pathology Component Outlook (Revenue, USD Million, 2018 - 2030)
- Software
- Services
Computational Pathology Application Outlook (Revenue, USD Million, 2018 - 2030)
- Disease Diagnosis
- Drug Discovery & Development
- Academic Research
Computational Pathology Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Machine Learning (ML)
  - Deep Learning
  - Others
- Natural Language Processing (NLP) Models
- Computer Vision
- Others
Computational Pathology End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Other
Computational Pathology Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Component Outlook (Revenue, USD Million, 2018 - 2030)
    - Software
    - Services
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Disease Diagnosis
    - Drug Discovery & Development
    - Academic Research
  - North America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Machine Learning (ML)
      - Deep Learning
      - Others
    - Natural Language Processing (NLP) Models
    - Computer Vision
    - Others
  - North America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals and Diagnostic Labs
    - Biotechnology and Pharmaceutical Companies
    - Academic and Research Institutes
    - Other
  - U.S.
    - U.S. Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - U.S. Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - U.S. End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Canada
    - Canada Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Canada Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Canada End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Mexico
    - Mexico Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Mexico Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Mexico End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
- Europe
  - Europe Component Outlook (Revenue, USD Million, 2018 - 2030)
    - Software
    - Services
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Disease Diagnosis
    - Drug Discovery & Development
    - Academic Research
  - Europe Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Machine Learning (ML)
      - Deep Learning
      - Others
    - Natural Language Processing (NLP) Models
    - Computer Vision
    - Others
  - Europe End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals and Diagnostic Labs
    - Biotechnology and Pharmaceutical Companies
    - Academic and Research Institutes
    - Other
  - UK
    - UK Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - UK Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - UK Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - UK End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Germany
    - Germany Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Germany Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Germany End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - France
    - France Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - France Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - France End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Italy
    - Italy Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Italy Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Italy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Spain
    - Spain Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Spain Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Spain End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Denmark
    - Denmark Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Denmark Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Denmark End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Norway
    - Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Sweden
    - Sweden Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Sweden Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Sweden End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
- Asia Pacific
  - Asia Pacific Component Outlook (Revenue, USD Million, 2018 - 2030)
    - Software
    - Services
  - Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Disease Diagnosis
    - Drug Discovery & Development
    - Academic Research
  - Asia Pacific Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Machine Learning (ML)
      - Deep Learning
      - Others
    - Natural Language Processing (NLP) Models
    - Computer Vision
    - Others
  - Asia Pacific End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals and Diagnostic Labs
    - Biotechnology and Pharmaceutical Companies
    - Academic and Research Institutes
    - Other
  - China
    - China Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - China Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - China End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - India
    - India Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - India Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - India End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Japan
    - Japan Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Japan Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Japan End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - South Korea
    - South Korea Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - South Korea Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - South Korea End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Australia
    - Australia Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Australia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Australia End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Thailand
    - Thailand Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Thailand Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Thailand End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
- Latin America
  - Latin America Component Outlook (Revenue, USD Million, 2018 - 2030)
    - Software
    - Services
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Disease Diagnosis
    - Drug Discovery & Development
    - Academic Research
  - Latin America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Machine Learning (ML)
      - Deep Learning
      - Others
    - Natural Language Processing (NLP) Models
    - Computer Vision
    - Others
  - Latin America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals and Diagnostic Labs
    - Biotechnology and Pharmaceutical Companies
    - Academic and Research Institutes
    - Other
  - Brazil
    - Brazil Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Brazil Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Brazil End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Argentina
    - Argentina Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Argentina Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Argentina End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
- Middle East and Africa
  - Middle East and Africa Component Outlook (Revenue, USD Million, 2018 - 2030)
    - Software
    - Services
  - Middle East and Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Disease Diagnosis
    - Drug Discovery & Development
    - Academic Research
  - Middle East and Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Machine Learning (ML)
      - Deep Learning
      - Others
    - Natural Language Processing (NLP) Models
    - Computer Vision
    - Others
  - Middle East and Africa End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals and Diagnostic Labs
    - Biotechnology and Pharmaceutical Companies
    - Academic and Research Institutes
    - Other
  - South Africa
    - South Africa Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - South Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - South Africa End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Saudi Arabia
    - Saudi Arabia Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Saudi Arabia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Saudi Arabia End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - UAE
    - UAE Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - UAE Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - UAE End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other
  - Kuwait
    - Kuwait Component Outlook (Revenue, USD Million, 2018 - 2030)
      - Software
      - Services
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Disease Diagnosis
      - Drug Discovery & Development
      - Academic Research
    - Kuwait Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Machine Learning (ML)
        
        Deep Learning
        
        Others
      - Natural Language Processing (NLP) Models
      - Computer Vision
      - Others
    - Kuwait End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals and Diagnostic Labs
      - Biotechnology and Pharmaceutical Companies
      - Academic and Research Institutes
      - Other

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.